Journey Medical Corp
NASDAQ:DERM

Watchlist Manager
Journey Medical Corp Logo
Journey Medical Corp
NASDAQ:DERM
Watchlist
Price: 5.55 USD -3.31% Market Closed
Market Cap: 111m USD
Have any thoughts about
Journey Medical Corp?
Write Note

Journey Medical Corp
Intangible Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Journey Medical Corp
Intangible Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Intangible Assets CAGR 3Y CAGR 5Y CAGR 10Y
Journey Medical Corp
NASDAQ:DERM
Intangible Assets
$20.3m
CAGR 3-Years
11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Intangible Assets
$39.5B
CAGR 3-Years
-6%
CAGR 5-Years
-4%
CAGR 10-Years
4%
Bristol-Myers Squibb Co
NYSE:BMY
Intangible Assets
$27B
CAGR 3-Years
-16%
CAGR 5-Years
93%
CAGR 10-Years
32%
Pfizer Inc
NYSE:PFE
Intangible Assets
$61.2B
CAGR 3-Years
33%
CAGR 5-Years
9%
CAGR 10-Years
5%
Merck & Co Inc
NYSE:MRK
Intangible Assets
$17B
CAGR 3-Years
8%
CAGR 5-Years
7%
CAGR 10-Years
-2%
Eli Lilly and Co
NYSE:LLY
Intangible Assets
$6.5B
CAGR 3-Years
-6%
CAGR 5-Years
0%
CAGR 10-Years
3%
No Stocks Found

Journey Medical Corp
Glance View

Market Cap
115m USD
Industry
Pharmaceuticals

Journey Medical Corp. operates as a commercial-stage pharmaceutical company, which engages in developing, acquiring, licensing and commercializing of dermatology products. The company is headquartered in Scottsdale, Arizona and currently employs 90 full-time employees. The company went IPO on 2021-11-12. The company is focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company provides nine products that help treat and heal common skin conditions, such as Qbrexza, Accutane, Targadox, Ximino, Exelderm Cream and Solution, Ceracade Skin Emulsion, Luxamend Wound Cream, AMZEEQ and ZILXI. Its product Qbrexza is a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, which is an oral isotretinoin drug for the treatment of severe recalcitrant severe acne; Targadox, which is an oral doxycycline drug for adjunctive therapy for acne; Ximino, which is an oral minocycline drug for the treatment of moderate to severe acne; Exelderm Cream and Solution is an antifungal intended for topical use; Ceracade Skin Emulsion is used to treat dry skin conditions; AMZEEQ is used for the treatment of acne and ZILXI, for the treatment of rosacea.

DERM Intrinsic Value
4.22 USD
Overvaluation 24%
Intrinsic Value
Price

See Also

What is Journey Medical Corp's Intangible Assets?
Intangible Assets
20.3m USD

Based on the financial report for Dec 31, 2023, Journey Medical Corp's Intangible Assets amounts to 20.3m USD.

What is Journey Medical Corp's Intangible Assets growth rate?
Intangible Assets CAGR 3Y
11%

Over the last year, the Intangible Assets growth was -25%. The average annual Intangible Assets growth rates for Journey Medical Corp have been 11% over the past three years .

Back to Top